DEA schedule

Is phentermine and topiramate a controlled substance?

Federal schedule for phentermine and topiramate from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

Yes. Phentermine and topiramate is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Phentermine (Schedule IV).

Run it in Rivvi

Which 2027 plans near you dropped or restricted phentermine and topiramate?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Phentermine and Topiramate
SourceWhat it lists
FDA NDC directory16 prescription listings from 4 labelers, all Schedule IV
DEA controlled substances listPhentermine: Schedule IV

DEA list entry

DEA list entries for phentermine and topiramate
SubstanceDEA codeScheduleNarcoticOther namesMatch
Phentermine1640IVNoIonamin; Fastin; Adipex-P; Obe-Nix; ZantrylListed by name

Phentermine and Topiramate NDC listings

NDC listings for Phentermine and Topiramate
NDCProductFormStrengthLabelerDEA schedule
62541-203Qsymiacapsule, extended release11.25 mg/1; 69 mg/1Vivus LLCCIV
62541-204Qsymiacapsule, extended release15 mg/1; 92 mg/1Vivus LLCCIV
62541-201Qsymiacapsule, extended release3.75 mg/1; 23 mg/1Vivus LLCCIV
62541-202Qsymiacapsule, extended release7.5 mg/1; 46 mg/1Vivus LLCCIV
0480-2299Phentermine and topiramatecapsule, extended release11.25 mg/1; 69 mg/1Teva Pharmaceuticals, Inc.CIV
66993-782phentermine and topiramatecapsule, extended release11.25 mg/1; 69 mg/1Prasco LaboratoriesCIV
0480-3295Phentermine and topiramatecapsule, extended release15 mg/1; 92 mg/1Teva Pharmaceuticals, Inc.CIV
66993-783phentermine and topiramatecapsule, extended release15 mg/1; 92 mg/1Prasco LaboratoriesCIV
0480-3297Phentermine and topiramatecapsule, extended release3.75 mg/1; 23 mg/1Teva Pharmaceuticals, Inc.CIV
66993-780phentermine and topiramatecapsule, extended release3.75 mg/1; 23 mg/1Prasco LaboratoriesCIV
0480-3296Phentermine and topiramatecapsule, extended release7.5 mg/1; 46 mg/1Teva Pharmaceuticals, Inc.CIV
66993-781phentermine and topiramatecapsule, extended release7.5 mg/1; 46 mg/1Prasco LaboratoriesCIV
43598-626Phentermine and Topiramate Extended-Releasecapsule11.25 mg/1; 69 mg/1Dr.Reddys Laboratories IncCIV
43598-627Phentermine and Topiramate Extended-Releasecapsule15 mg/1; 92 mg/1Dr.Reddys Laboratories IncCIV
43598-624Phentermine and Topiramate Extended-Releasecapsule3.75 mg/1; 23 mg/1Dr.Reddys Laboratories IncCIV
43598-625Phentermine and Topiramate Extended-Releasecapsule7.5 mg/1; 46 mg/1Dr.Reddys Laboratories IncCIV

Questions

Is phentermine and topiramate a controlled substance?

Yes. Phentermine and topiramate is a Schedule IV controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Phentermine (Schedule IV).

Is phentermine and topiramate a narcotic?

No. The DEA list does not mark phentermine and topiramate as a narcotic (NARC = N) and places it in Schedule IV. Its FDA established pharmacologic class is Sympathomimetic Amine Anorectic.

What schedule is phentermine and topiramate?

Phentermine and topiramate is Schedule IV in the FDA NDC directory, which matches the DEA controlled substances list.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Phentermine and Topiramate

Try it on your own data today.

Free to start. Most teams are using it the same day.